Cancer Cell, ISSN 1535-6108, 10/2013, Volume 24, Issue 4, pp. 423 - 437
MLL fusion proteins in leukemia induce aberrant transcriptional elongation and associated chromatin perturbations; however, the upstream signaling pathways and...
GENE-EXPRESSION SIGNATURE | H3K79 METHYLATION | STEM-CELLS | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | TRANSCRIPTION ELONGATION | EMBRYONIC STEM | ACUTE MYELOID-LEUKEMIA | MIXED-LINEAGE LEUKEMIA | MLL-AF9-INDUCED LEUKEMOGENESIS | P-TEFB | CELL BIOLOGY | Chromatin - metabolism | Promoter Regions, Genetic | Myeloid-Lymphoid Leukemia Protein - metabolism | Prognosis | Signal Transduction | Cell Survival | Histone-Lysine N-Methyltransferase | Epigenesis, Genetic | Genomics | Humans | NF-kappa B - metabolism | Leukemia - metabolism | Gene Expression Regulation, Leukemic | Dose-Response Relationship, Drug | Animals | I-kappa B Kinase - metabolism | Myeloid-Lymphoid Leukemia Protein - physiology | Time Factors | Transcription Factor RelA - metabolism | Cell Line, Tumor | Transcription, Genetic | Mice | Leukemia - genetics | HOX | NF-κB | leukemia | MLL | MEIS
GENE-EXPRESSION SIGNATURE | H3K79 METHYLATION | STEM-CELLS | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | TRANSCRIPTION ELONGATION | EMBRYONIC STEM | ACUTE MYELOID-LEUKEMIA | MIXED-LINEAGE LEUKEMIA | MLL-AF9-INDUCED LEUKEMOGENESIS | P-TEFB | CELL BIOLOGY | Chromatin - metabolism | Promoter Regions, Genetic | Myeloid-Lymphoid Leukemia Protein - metabolism | Prognosis | Signal Transduction | Cell Survival | Histone-Lysine N-Methyltransferase | Epigenesis, Genetic | Genomics | Humans | NF-kappa B - metabolism | Leukemia - metabolism | Gene Expression Regulation, Leukemic | Dose-Response Relationship, Drug | Animals | I-kappa B Kinase - metabolism | Myeloid-Lymphoid Leukemia Protein - physiology | Time Factors | Transcription Factor RelA - metabolism | Cell Line, Tumor | Transcription, Genetic | Mice | Leukemia - genetics | HOX | NF-κB | leukemia | MLL | MEIS
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 5/2003, Volume 36, Issue 10, pp. 1221 - 1228
A randomized, blinded, multicenter trial was conducted to compare fluconazole (800 mg per day) plus placebo with fluconazole plus amphotericin B (AmB)...
Antifungals | Logistic regression | Infectious diseases | Major Articles | Placebos | Cultural groups | Infections | Candidemia | Dosage | Blood | Catheters | CANDIDIASIS | INFECTIOUS DISEASES | MICROBIOLOGY | INFECTIONS | IMMUNOLOGY | CLINICAL-TRIALS | Fungemia - physiopathology | Antifungal Agents - adverse effects | Catheterization | Double-Blind Method | Candidiasis - physiopathology | Humans | Middle Aged | Fluconazole - adverse effects | Male | Treatment Outcome | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Amphotericin B - adverse effects | Neutropenia - etiology | Candidiasis - drug therapy | Fungemia - drug therapy | Adult | Female | Candida - drug effects | Amphotericin B - therapeutic use | Drug Therapy, Combination | Evaluation | Candidiasis | Dosage and administration | Amphotericin B | Fluconazole | Drug therapy
Antifungals | Logistic regression | Infectious diseases | Major Articles | Placebos | Cultural groups | Infections | Candidemia | Dosage | Blood | Catheters | CANDIDIASIS | INFECTIOUS DISEASES | MICROBIOLOGY | INFECTIONS | IMMUNOLOGY | CLINICAL-TRIALS | Fungemia - physiopathology | Antifungal Agents - adverse effects | Catheterization | Double-Blind Method | Candidiasis - physiopathology | Humans | Middle Aged | Fluconazole - adverse effects | Male | Treatment Outcome | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Amphotericin B - adverse effects | Neutropenia - etiology | Candidiasis - drug therapy | Fungemia - drug therapy | Adult | Female | Candida - drug effects | Amphotericin B - therapeutic use | Drug Therapy, Combination | Evaluation | Candidiasis | Dosage and administration | Amphotericin B | Fluconazole | Drug therapy
Journal Article
DMM Disease Models and Mechanisms, ISSN 1754-8403, 09/2017, Volume 10, Issue 9, pp. 1109 - 1115
Alveolar rhabdomyosarcoma (aRMS) is a pediatric soft tissue cancer commonly associated with a chromosomal translocation that leads to the expression of a...
IKKβ | NFκB | Rhabdomyosarcoma | Cancer | CHILDHOOD RHABDOMYOSARCOMA | ACTIVATION | TISSUE SARCOMA COMMITTEE | CYCLIN D1 | PHOSPHORYLATION | PATHOLOGY | CHILDRENS ONCOLOGY GROUP | CELL BIOLOGY | IKK beta | PATHWAY | SKELETAL MYOGENESIS | MICE | NF kappa B | PANCREATIC-CANCER CELLS | Humans | NF-kappa B - metabolism | Mice, SCID | Allografts - drug effects | Genetic Complementation Test | Peptides - pharmacology | Proto-Oncogene Proteins c-bcl-2 - metabolism | Phenotype | Animals | I-kappa B Kinase - metabolism | Rhabdomyosarcoma, Alveolar - metabolism | Signal Transduction - drug effects | Gene Deletion | Dogs | Cell Line, Tumor | Female | Rhabdomyosarcoma, Alveolar - pathology | Cell Proliferation - drug effects | 304
IKKβ | NFκB | Rhabdomyosarcoma | Cancer | CHILDHOOD RHABDOMYOSARCOMA | ACTIVATION | TISSUE SARCOMA COMMITTEE | CYCLIN D1 | PHOSPHORYLATION | PATHOLOGY | CHILDRENS ONCOLOGY GROUP | CELL BIOLOGY | IKK beta | PATHWAY | SKELETAL MYOGENESIS | MICE | NF kappa B | PANCREATIC-CANCER CELLS | Humans | NF-kappa B - metabolism | Mice, SCID | Allografts - drug effects | Genetic Complementation Test | Peptides - pharmacology | Proto-Oncogene Proteins c-bcl-2 - metabolism | Phenotype | Animals | I-kappa B Kinase - metabolism | Rhabdomyosarcoma, Alveolar - metabolism | Signal Transduction - drug effects | Gene Deletion | Dogs | Cell Line, Tumor | Female | Rhabdomyosarcoma, Alveolar - pathology | Cell Proliferation - drug effects | 304
Journal Article
Current Opinion in Pediatrics, ISSN 1040-8703, 2018, Volume 30, Issue 5, pp. 689 - 697
Purpose of review This review describes the impact of recommendations for routine immunization of infants and children against hepatitis A and hepatitis B, the...
Vaccine | Hepatitis A | Hepatitis B | UNITED-STATES | VIRUS-INFECTION | PERINATAL TRANSMISSION | hepatitis A | hepatitis B | COMMUNITY-WIDE OUTBREAK | ADULT-POPULATIONS | IMMUNIZATION | vaccine | IMPACT | ADOLESCENTS | PEDIATRICS | VACCINATION COVERAGE | SEMIDRIED TOMATOES | Prevention | Pediatrics | Vaccination | Management | Methods
Vaccine | Hepatitis A | Hepatitis B | UNITED-STATES | VIRUS-INFECTION | PERINATAL TRANSMISSION | hepatitis A | hepatitis B | COMMUNITY-WIDE OUTBREAK | ADULT-POPULATIONS | IMMUNIZATION | vaccine | IMPACT | ADOLESCENTS | PEDIATRICS | VACCINATION COVERAGE | SEMIDRIED TOMATOES | Prevention | Pediatrics | Vaccination | Management | Methods
Journal Article
Organic Letters, ISSN 1523-7060, 09/2014, Volume 16, Issue 17, pp. 4460 - 4463
Progress toward the welwitindolinone alkaloid N-methylwelwitindolinone B isothiocyanate is reported. A key reaction to synthesize the [4.3.1] bicycle embedded...
CONSTRUCTION | ESTERS | CHEMISTRY | CHEMISTRY, ORGANIC | WELWISTATIN | FISCHERINDOLES | EFFICIENT | C ISOTHIOCYANATE | OXIDIZED WELWITINDOLINONES | ALKALOIDS | SKELETON | Molecular Structure | Indole Alkaloids - chemical synthesis | Indole Alkaloids - chemistry | Cyanobacteria - chemistry
CONSTRUCTION | ESTERS | CHEMISTRY | CHEMISTRY, ORGANIC | WELWISTATIN | FISCHERINDOLES | EFFICIENT | C ISOTHIOCYANATE | OXIDIZED WELWITINDOLINONES | ALKALOIDS | SKELETON | Molecular Structure | Indole Alkaloids - chemical synthesis | Indole Alkaloids - chemistry | Cyanobacteria - chemistry
Journal Article
Nature, ISSN 0028-0836, 08/2018, Volume 560, Issue 7717, pp. 253 - 257
Acetylation of histones by lysine acetyltransferases (KATs) is essential for chromatin organization and function(1). Among the genes coding for the MYST family...
MAINTENANCE | PROTEIN | RAS | MULTIDISCIPLINARY SCIENCES | HEMATOPOIETIC STEM-CELLS | GENE-EXPRESSION | MOZ | CYCLE PROGRESSION | P16(INK4A) | FAMILY | P53 | Histone Acetyltransferases - deficiency | Histones - chemistry | Cellular Senescence - drug effects | Histone Acetyltransferases - genetics | Male | Benzenesulfonates - therapeutic use | Benzenesulfonates - pharmacology | Lymphoma - drug therapy | Fibroblasts | Lymphoma - enzymology | Lymphoma - pathology | Lysine - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Hydrazines - pharmacology | Hydrazines - therapeutic use | Mice, Inbred C57BL | Cells, Cultured | Lymphoma - genetics | Models, Molecular | Sulfonamides - pharmacology | Acetylation - drug effects | Animals | Sulfonamides - therapeutic use | Histone Acetyltransferases - antagonists & inhibitors | Cell Proliferation - drug effects | Mice | Drug Development | Histones - metabolism | Lysine - chemistry | Analysis | Transferases | Oncology, Experimental | Histones | Physiological aspects | Acetylation | Research | Gene expression | Tumors | Cancer | Chromatin | Senescence | Transcription | Leukemia | DNA damage | Hepatocellular carcinoma | Myc protein | Drug development | Proteins | Cell cycle | Coenzyme A | Cyclin-dependent kinase inhibitors | Deoxyribonucleic acid--DNA | Zebrafish | INK4 protein | Bioavailability | Lymphoma | Suppressors | Chromosome translocations | Inhibitors | Lysine | Stem cells | Lymphomas | Kinetics
MAINTENANCE | PROTEIN | RAS | MULTIDISCIPLINARY SCIENCES | HEMATOPOIETIC STEM-CELLS | GENE-EXPRESSION | MOZ | CYCLE PROGRESSION | P16(INK4A) | FAMILY | P53 | Histone Acetyltransferases - deficiency | Histones - chemistry | Cellular Senescence - drug effects | Histone Acetyltransferases - genetics | Male | Benzenesulfonates - therapeutic use | Benzenesulfonates - pharmacology | Lymphoma - drug therapy | Fibroblasts | Lymphoma - enzymology | Lymphoma - pathology | Lysine - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Hydrazines - pharmacology | Hydrazines - therapeutic use | Mice, Inbred C57BL | Cells, Cultured | Lymphoma - genetics | Models, Molecular | Sulfonamides - pharmacology | Acetylation - drug effects | Animals | Sulfonamides - therapeutic use | Histone Acetyltransferases - antagonists & inhibitors | Cell Proliferation - drug effects | Mice | Drug Development | Histones - metabolism | Lysine - chemistry | Analysis | Transferases | Oncology, Experimental | Histones | Physiological aspects | Acetylation | Research | Gene expression | Tumors | Cancer | Chromatin | Senescence | Transcription | Leukemia | DNA damage | Hepatocellular carcinoma | Myc protein | Drug development | Proteins | Cell cycle | Coenzyme A | Cyclin-dependent kinase inhibitors | Deoxyribonucleic acid--DNA | Zebrafish | INK4 protein | Bioavailability | Lymphoma | Suppressors | Chromosome translocations | Inhibitors | Lysine | Stem cells | Lymphomas | Kinetics
Journal Article
Leukemia, ISSN 0887-6924, 10/2016, Volume 30, Issue 10, pp. 2116 - 2119
Journal Article
The Lancet, ISSN 0140-6736, 2005, Volume 366, Issue 9495, pp. 1435 - 1442
Voriconazole has proven efficacy against invasive aspergillosis and oesophageal candidiasis. This multicentre, randomised, non-inferiority study compared...
MULTICENTER TRIAL | MEDICINE, GENERAL & INTERNAL | INVASIVE ASPERGILLOSIS | INTERNATIONAL SURVEILLANCE | CANDIDEMIA | THERAPY | IN-VITRO ACTIVITIES | CANDIDIASIS | AGENTS | BLOOD-STREAM INFECTIONS | FUNGAL-INFECTIONS | Triazoles - adverse effects | Antifungal Agents - adverse effects | Humans | Middle Aged | Fluconazole - adverse effects | Male | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Candidiasis - drug therapy | Voriconazole | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Triazoles - therapeutic use | Candidiasis - mortality | Treatment Outcome | Amphotericin B - adverse effects | Candidiasis - classification | Pyrimidines - therapeutic use | Adolescent | Pyrimidines - adverse effects | Aged | Amphotericin B - therapeutic use | APACHE | Evaluation | Candidiasis | Dosage and administration | Amphotericin B | Fluconazole | Drug therapy | Research | Comparative analysis | Fungi | Prescription drugs | Infections | Medical treatment | Blood | Pharmaceuticals
MULTICENTER TRIAL | MEDICINE, GENERAL & INTERNAL | INVASIVE ASPERGILLOSIS | INTERNATIONAL SURVEILLANCE | CANDIDEMIA | THERAPY | IN-VITRO ACTIVITIES | CANDIDIASIS | AGENTS | BLOOD-STREAM INFECTIONS | FUNGAL-INFECTIONS | Triazoles - adverse effects | Antifungal Agents - adverse effects | Humans | Middle Aged | Fluconazole - adverse effects | Male | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Candidiasis - drug therapy | Voriconazole | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Triazoles - therapeutic use | Candidiasis - mortality | Treatment Outcome | Amphotericin B - adverse effects | Candidiasis - classification | Pyrimidines - therapeutic use | Adolescent | Pyrimidines - adverse effects | Aged | Amphotericin B - therapeutic use | APACHE | Evaluation | Candidiasis | Dosage and administration | Amphotericin B | Fluconazole | Drug therapy | Research | Comparative analysis | Fungi | Prescription drugs | Infections | Medical treatment | Blood | Pharmaceuticals
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 2002, Volume 109, Issue 12, pp. 1625 - 1633
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/1999, Volume 5, Issue 1, pp. 119 - 127
Pancreatic adenocarcinoma is a leading cause of adult cancer mortality in the United States. Recent studies have revealed that point mutation of the K- ras...
TRANSFORMATION | PREOPERATIVE CHEMORADIATION | KINASE COMPLEX | ONCOGENE | ONCOLOGY | INDUCED APOPTOSIS | RAS | PHOSPHORYLATION | ALPHA | EXPRESSION | CANCER | Immunohistochemistry | Amino Acid Sequence | Cricetinae | Pancreatic Neoplasms - metabolism | DNA, Neoplasm - metabolism | Humans | Gene Expression Regulation, Neoplastic | Molecular Sequence Data | Transcription Factor RelA | NF-kappa B - metabolism | Pancreatic Neoplasms - genetics | Point Mutation | Adenocarcinoma - metabolism | Animals | Mesocricetus | Adult | Adenocarcinoma - genetics | Tumor Cells, Cultured | Genes, ras
TRANSFORMATION | PREOPERATIVE CHEMORADIATION | KINASE COMPLEX | ONCOGENE | ONCOLOGY | INDUCED APOPTOSIS | RAS | PHOSPHORYLATION | ALPHA | EXPRESSION | CANCER | Immunohistochemistry | Amino Acid Sequence | Cricetinae | Pancreatic Neoplasms - metabolism | DNA, Neoplasm - metabolism | Humans | Gene Expression Regulation, Neoplastic | Molecular Sequence Data | Transcription Factor RelA | NF-kappa B - metabolism | Pancreatic Neoplasms - genetics | Point Mutation | Adenocarcinoma - metabolism | Animals | Mesocricetus | Adult | Adenocarcinoma - genetics | Tumor Cells, Cultured | Genes, ras
Journal Article
JOURNAL OF CLINICAL INVESTIGATION, ISSN 0021-9738, 06/2002, Volume 109, Issue 12, pp. 1625 - 1633
Estrogen is thought to contribute to the increased frequency of autoimmune disorders occurring in females, but a molecular basis for its effects on...
BCL-2 TRANSGENE | MEDICINE, RESEARCH & EXPERIMENTAL | INHIBITS APOPTOSIS | SYSTEMIC LUPUS-ERYTHEMATOSUS | BONE-MARROW | NEGATIVE SELECTION | SEX STEROID REGULATION | GERMINAL CENTER | AUTOIMMUNE-DISEASE | RECEPTOR-ALPHA | CUTTING EDGE
BCL-2 TRANSGENE | MEDICINE, RESEARCH & EXPERIMENTAL | INHIBITS APOPTOSIS | SYSTEMIC LUPUS-ERYTHEMATOSUS | BONE-MARROW | NEGATIVE SELECTION | SEX STEROID REGULATION | GERMINAL CENTER | AUTOIMMUNE-DISEASE | RECEPTOR-ALPHA | CUTTING EDGE
Journal Article
The Journal of Pediatrics, ISSN 0022-3476, 06/2018, Volume 197, pp. 198 - 206.e2
To evaluate the natural course of disease progression in patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB), identify potential end...
disease progression | biomarkers | prospective study | mucopolysaccharidosis type III B | DIAGNOSTIC-TEST | HETEROGENEITY | MUCOPOLYSACCHARIDOSIS TYPE IIIB | THERAPY | CLINICAL-TRIAL | QUANTIFICATION | PHENOTYPE | PEDIATRICS | CEREBROSPINAL-FLUID | GLYCOSAMINOGLYCAN | CHILDREN | Biomarkers - metabolism | Neurodevelopmental Disorders - epidemiology | Brain - diagnostic imaging | Prospective Studies | Humans | Child, Preschool | Infant | Male | Heparitin Sulfate - metabolism | Disease Progression | Mucopolysaccharidosis III - complications | Young Adult | Magnetic Resonance Imaging | Mucopolysaccharidosis III - diagnosis | Cerebrospinal Fluid - metabolism | Adolescent | Adult | Female | Child | Glycosaminoglycans - urine | Longitudinal Studies | Neurodevelopmental Disorders - etiology | Enzymes | Development and progression | Nervous system diseases | Infants | Child development | Sulfates
disease progression | biomarkers | prospective study | mucopolysaccharidosis type III B | DIAGNOSTIC-TEST | HETEROGENEITY | MUCOPOLYSACCHARIDOSIS TYPE IIIB | THERAPY | CLINICAL-TRIAL | QUANTIFICATION | PHENOTYPE | PEDIATRICS | CEREBROSPINAL-FLUID | GLYCOSAMINOGLYCAN | CHILDREN | Biomarkers - metabolism | Neurodevelopmental Disorders - epidemiology | Brain - diagnostic imaging | Prospective Studies | Humans | Child, Preschool | Infant | Male | Heparitin Sulfate - metabolism | Disease Progression | Mucopolysaccharidosis III - complications | Young Adult | Magnetic Resonance Imaging | Mucopolysaccharidosis III - diagnosis | Cerebrospinal Fluid - metabolism | Adolescent | Adult | Female | Child | Glycosaminoglycans - urine | Longitudinal Studies | Neurodevelopmental Disorders - etiology | Enzymes | Development and progression | Nervous system diseases | Infants | Child development | Sulfates
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 01/2003, Volume 111, Issue 2, pp. 275 - 283
Prolactin is a peptide hormone produced by the anterior pituitary gland that is critical in lactation. Prolactin can also be produced by lymphocytes, and both...
MEDICINE, RESEARCH & EXPERIMENTAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | SEX-HORMONES | HYPERPROLACTINEMIA | BROMOCRIPTINE | TOLERANCE | LYMPHOID-CELLS | AUTOIMMUNE-DISEASE | EXPRESSION | DISEASE-ACTIVITY | LYMPHOCYTES
MEDICINE, RESEARCH & EXPERIMENTAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | SEX-HORMONES | HYPERPROLACTINEMIA | BROMOCRIPTINE | TOLERANCE | LYMPHOID-CELLS | AUTOIMMUNE-DISEASE | EXPRESSION | DISEASE-ACTIVITY | LYMPHOCYTES
Journal Article
14.
Full Text
E2A-PBX1 remodels oncogenic signaling networks in B-cell precursor acute lymphoid leukemia
Cancer Research, ISSN 0008-5472, 12/2016, Volume 76, Issue 23, pp. 6937 - 6949
There is limited understanding of how signaling pathways are altered by oncogenic fusion transcription factors that drive leukemogenesis. To address this, we...
KINASE INHIBITOR DASATINIB | ACTIVATION | SYK | ONCOLOGY | TYROSINE KINASE | ACUTE LYMPHOBLASTIC-LEUKEMIA | DISEASE | CHRONIC LYMPHOCYTIC-LEUKEMIA | MICE | ZAP-70 EXPRESSION | LCK GENE | Gene Expression | Oncogene Proteins, Fusion - metabolism | Signal Transduction | Homeodomain Proteins - metabolism | Humans | Mice, Transgenic | Homeodomain Proteins - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Animals | Oncogene Proteins, Fusion - genetics | Mice | B-Lymphocytes - metabolism | pre-BCR | signaling pathways | Acute lymphoblastic leukemia | genetic interactions | E2A-PBX1
KINASE INHIBITOR DASATINIB | ACTIVATION | SYK | ONCOLOGY | TYROSINE KINASE | ACUTE LYMPHOBLASTIC-LEUKEMIA | DISEASE | CHRONIC LYMPHOCYTIC-LEUKEMIA | MICE | ZAP-70 EXPRESSION | LCK GENE | Gene Expression | Oncogene Proteins, Fusion - metabolism | Signal Transduction | Homeodomain Proteins - metabolism | Humans | Mice, Transgenic | Homeodomain Proteins - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Animals | Oncogene Proteins, Fusion - genetics | Mice | B-Lymphocytes - metabolism | pre-BCR | signaling pathways | Acute lymphoblastic leukemia | genetic interactions | E2A-PBX1
Journal Article